계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Abcodia
company
About
Abcodia is a biotechnology company that focuses on the discovery and validation of biomarkers for cancer screening.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- £5.25M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process.Abcodia was founded in 2010 and is based in Cambridge, UK.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£5.25M
Abcodia has raised a total of
£5.25M
in funding over 2 rounds. Their latest funding was raised on
May 18, 2015 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 18, 2015 | Series B | £5.25M | 1 |
Cambridge Innovation Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Abcodia is funded by 1 investors.
Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cambridge Innovation Capital
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
